Chuokeizai-Sha Holdings, Inc.
Chuokeizai-Sha Holdings, Inc. (9476.T) Financial Performance & Income Statement Overview
Explore the financials of Chuokeizai-Sha Holdings, Inc. (9476.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Chuokeizai-Sha Holdings, Inc. (9476.T) Income Statement & Financial Overview
View the income breakdown for Chuokeizai-Sha Holdings, Inc. 9476.T across both annual and quarterly reports.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $930.66M | $767.00M | $826.00M | $704.00M |
Cost of Revenue | $550.05M | $519.00M | $515.00M | $478.00M |
Gross Profit | $380.61M | $248.00M | $311.00M | $226.00M |
Gross Profit Ratio | $0.41 | $0.32 | $0.38 | $0.32 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $237.74M | $253.00M | $207.00M | $233.00M |
Operating Expenses | $237.74M | $253.00M | $268.00M | $232.00M |
Total Costs & Expenses | $787.79M | $772.00M | $783.00M | $710.00M |
Interest Income | $464000.00 | $390000.00 | $0.00 | $9.00M |
Interest Expense | $683000.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $11.97M | $12.25M | $12.25M | $12.04M |
EBITDA | $157.71M | $7.25M | $56.25M | $17.15M |
EBITDA Ratio | $0.17 | $0.009 | $0.07 | $0.02 |
Operating Income | $142.87M | -$5.00M | $43.00M | -$6.00M |
Operating Income Ratio | $0.15 | -$0.007 | $0.05 | -$0.009 |
Other Income/Expenses (Net) | $2.19M | $9.00M | -$131.00M | $11.00M |
Income Before Tax | $145.06M | $4.00M | -$88.00M | $5.00M |
Income Before Tax Ratio | $0.16 | $0.005 | -$0.11 | $0.007 |
Income Tax Expense | $18.47M | $1.00M | $136.00M | $4.00M |
Net Income | $126.59M | $3.00M | -$224.00M | $1.00M |
Net Income Ratio | $0.14 | $0.004 | -$0.27 | $0.001 |
EPS | $32.69 | $0.77 | -$57.99 | $0.26 |
Diluted EPS | $32.69 | $0.77 | -$57.99 | $0.26 |
Weighted Avg Shares Outstanding | $3.87M | $3.87M | $3.86M | $3.86M |
Weighted Avg Shares Outstanding (Diluted) | $3.87M | $3.87M | $3.86M | $3.86M |
Over the past four quarters, Chuokeizai-Sha Holdings, Inc. demonstrated steady revenue growth, increasing from $704.00M in Q3 2024 to $930.66M in Q2 2025. Operating income reached $142.87M in Q2 2025, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $157.71M, reflecting operational efficiency. Net income rose to $126.59M, with EPS at $32.69. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan